$2.430
-0.105 (-4.33%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
FATE Prediction & Forecast by Similar Chart Analysis
Alphio's FATE stock price prediction model matches the current Fate Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $2.43 (+0.01%). The 1-week path is $2.45 (+0.98%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Fate Therapeutics Inc Stock?
Fate Therapeutics Inc is a good buy right now due to its recent FDA clearance for the FT839 CAR T-cell product, which has the potential to significantly impact autoimmune disease treatment. The current price of $2.43 is well below the analyst price target of $4 from Jefferies and $7 from H.C. Wainwright, indicating substantial upside potential. Additionally, the stock has shown a year-to-date change of +146.35%, reflecting strong investor interest and confidence in its future prospects. However, the main risk is the negative earnings trend, with an EPS of -0.25 reported in the last quarter, which investors should monitor closely.
FATE stock price ended at $2.43 on Friday, after losing -4.33%
Fate Therapeutics Inc (FATE) last closed at $2.43, losing -4.33%. These facts feed the 1-day and 1-week FATE price prediction above.
Analyst Consensus
Fate Therapeutics Inc (FATE): 6 buy, 0 hold, 0 sell. Outlook: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Forecast Drivers
Fate Therapeutics Inc (FATE) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bullish
Similar Chart Patterns
Stocks whose recent price path most closely matches FATE, ranked by similarity.
Seasonality analysis for FATE
Historically the probability of a positive August return for FATE is 46.03%. February offers the highest probability of a positive month at 67.24%, while October is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for FATE
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $1.39 | $1.51 | $1.68 | -37.80% |
| Sep 2026 | $1.49 | $1.67 | $1.86 | -31.45% |
| Oct 2026 | $1.06 | $1.28 | $1.42 | -47.31% |
| Nov 2026 | $1.08 | $1.34 | $1.47 | -44.82% |
| Dec 2026 | $1.27 | $1.48 | $1.58 | -38.98% |
In 2026, Fate Therapeutics Inc (FATE) is projected to range from $1.06 to $1.86.
Fate Therapeutics Inc 2026 monthly forecast
In Aug 2026, Fate Therapeutics Inc is projected to average $1.51, with a low of $1.39 and high of $1.68.
In Sep 2026, Fate Therapeutics Inc is projected to average $1.67, with a low of $1.49 and high of $1.86.
In Oct 2026, Fate Therapeutics Inc is projected to average $1.28, with a low of $1.06 and high of $1.42.
In Nov 2026, Fate Therapeutics Inc is projected to average $1.34, with a low of $1.08 and high of $1.47.
In Dec 2026, Fate Therapeutics Inc is projected to average $1.48, with a low of $1.27 and high of $1.58.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.